Work

423 Phase 1 dose escalation, safety and pharmacokinetic study of IT-101 (CRLX101), a novel nanopharmaceutical containing camptothecin, in advanced solid tumor cancer patients

Year: 2010

Type: article

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(10)72130-3

Authors: Y. Yen, T. Synold, G.J. Weiss, T. Schluep, J. Ryan

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1981975737

FWCI:

Cites:

Cited by: 6

Related to: 10